|
US20050239054A1
(en)
*
|
2002-04-26 |
2005-10-27 |
Arimilli Murty N |
Method and compositions for identifying anti-HIV therapeutic compounds
|
|
AU2003231766A1
(en)
*
|
2002-04-26 |
2003-11-10 |
Gilead Sciences, Inc. |
Non nucleoside reverse transcriptase inhibitors
|
|
US7351738B2
(en)
*
|
2002-11-27 |
2008-04-01 |
Elan Pharmaceuticals, Inc. |
Substituted ureas and carbamates
|
|
AU2004206827A1
(en)
|
2003-01-14 |
2004-08-05 |
Gilead Sciences, Inc. |
Compositions and methods for combination antiviral therapy
|
|
WO2004096233A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Nucleoside phosphonate conjugates
|
|
US20050261237A1
(en)
*
|
2003-04-25 |
2005-11-24 |
Boojamra Constantine G |
Nucleoside phosphonate analogs
|
|
US7470724B2
(en)
*
|
2003-04-25 |
2008-12-30 |
Gilead Sciences, Inc. |
Phosphonate compounds having immuno-modulatory activity
|
|
CN101410120A
(zh)
*
|
2003-04-25 |
2009-04-15 |
吉里德科学公司 |
抗炎的膦酸酯化合物
|
|
US7432261B2
(en)
*
|
2003-04-25 |
2008-10-07 |
Gilead Sciences, Inc. |
Anti-inflammatory phosphonate compounds
|
|
EP1620110A2
(en)
*
|
2003-04-25 |
2006-02-01 |
Gilead Sciences, Inc. |
Immunomodulator phosphonate conjugates
|
|
US7407965B2
(en)
*
|
2003-04-25 |
2008-08-05 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
WO2005002626A2
(en)
*
|
2003-04-25 |
2005-01-13 |
Gilead Sciences, Inc. |
Therapeutic phosphonate compounds
|
|
CA2522845A1
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
WO2004096237A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Phosphonate analogs for treating metabolic diseases
|
|
US20090247488A1
(en)
*
|
2003-04-25 |
2009-10-01 |
Carina Cannizzaro |
Anti-inflammatory phosphonate compounds
|
|
WO2004096287A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
|
|
EP1628685B1
(en)
*
|
2003-04-25 |
2010-12-08 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
WO2004096285A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-infective phosphonate conjugates
|
|
US7491794B2
(en)
*
|
2003-10-14 |
2009-02-17 |
Intermune, Inc. |
Macrocyclic compounds as inhibitors of viral replication
|
|
US7432273B2
(en)
*
|
2003-10-24 |
2008-10-07 |
Gilead Sciences, Inc. |
Phosphonate analogs of antimetabolites
|
|
WO2005044279A1
(en)
*
|
2003-10-24 |
2005-05-19 |
Gilead Sciences, Inc. |
Purine nucleoside phosphonate conjugates
|
|
AU2004290298A1
(en)
*
|
2003-10-24 |
2005-05-26 |
Gilead Sciences, Inc. |
Methods and compositions for identifying therapeutic compounds
|
|
CA2548951A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
US20050153990A1
(en)
*
|
2003-12-22 |
2005-07-14 |
Watkins William J. |
Phosphonate substituted kinase inhibitors
|
|
US20070281907A1
(en)
*
|
2003-12-22 |
2007-12-06 |
Watkins William J |
Kinase Inhibitor Phosphonate Conjugates
|
|
BRPI0417988A
(pt)
*
|
2003-12-22 |
2007-04-27 |
Gilead Sciences Inc |
análogos de fosfonato antivirais
|
|
CN1934093A
(zh)
*
|
2004-01-12 |
2007-03-21 |
吉里德科学公司 |
嘧啶基膦酸酯抗病毒化合物和使用方法
|
|
AU2005249363A1
(en)
*
|
2004-04-14 |
2005-12-15 |
Zhenhong R. Cai |
Phosphonate analogs of HIV integrase inhibitor compounds
|
|
ME03423B
(me)
*
|
2004-07-27 |
2020-01-20 |
Gilead Sciences Inc |
Fosfonatni analozi jedinjenja hiv inhibitora
|
|
AU2011218664B2
(en)
*
|
2004-07-27 |
2014-08-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
SG155939A1
(en)
*
|
2004-09-17 |
2009-10-29 |
Idenix Pharmaceuticals Inc |
Phosphoindoles as hiv inhibitors
|
|
ES2354338T3
(es)
*
|
2004-09-17 |
2011-03-14 |
Idenix Pharmaceuticals, Inc. |
Fosfoindoles como inhibidores de vih.
|
|
JP5067968B2
(ja)
|
2004-10-07 |
2012-11-07 |
ビテ ファーマシューティカルズ， インコーポレイテッド |
ジアミノアルカンアスパラギン酸プロテアーゼ阻害剤
|
|
EP1812012A4
(en)
|
2004-11-15 |
2010-02-17 |
Ceptyr Inc |
PROTEIN TYROSINE PHOSPHATASE INHIBITOR AND METHOD FOR THEIR USE
|
|
WO2006066074A2
(en)
|
2004-12-16 |
2006-06-22 |
The Regents Of The University Of California |
Lung-targeted drugs
|
|
BRPI0607827B8
(pt)
|
2005-02-25 |
2021-05-25 |
Janssen R & D Ireland |
composto precursor de inibidor de protease, processo para a produção do referido composto e seu uso
|
|
US8642577B2
(en)
*
|
2005-04-08 |
2014-02-04 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
|
US20070003608A1
(en)
*
|
2005-04-08 |
2007-01-04 |
Almond Merrick R |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
|
AR053845A1
(es)
|
2005-04-15 |
2007-05-23 |
Tibotec Pharm Ltd |
5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
|
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
|
CN102816170A
(zh)
|
2005-07-25 |
2012-12-12 |
因特蒙公司 |
C型肝炎病毒复制的新颖大环抑制剂
|
|
CA2616314A1
(en)
*
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
|
AU2006301966A1
(en)
*
|
2005-10-11 |
2007-04-19 |
Array Biopharma, Inc. |
Compounds and methods for inhibiting hepatitis C viral replication
|
|
TWI411607B
(zh)
|
2005-11-14 |
2013-10-11 |
Vitae Pharmaceuticals Inc |
天門冬胺酸蛋白酶抑制劑
|
|
TWI385173B
(zh)
|
2005-11-28 |
2013-02-11 |
Tibotec Pharm Ltd |
作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物
|
|
TWI432438B
(zh)
|
2005-11-28 |
2014-04-01 |
Tibotec Pharm Ltd |
作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物及衍生物
|
|
JP5231242B2
(ja)
*
|
2005-12-14 |
2013-07-10 |
シプラ・リミテッド |
ヌクレオチド及びヌクレオシド系逆転写酵素阻害剤（テノホビル及びラミブジン）を剤形の異なる部分に含む医薬組合せ
|
|
US20070167422A1
(en)
*
|
2006-01-18 |
2007-07-19 |
Yu Kwok S |
Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin
|
|
SI1999133T1
(sl)
*
|
2006-03-29 |
2013-10-30 |
Gilead Sciences, Inc. |
Postopek za pripravo HIV proteaznih inhibitorjev
|
|
EP2069356A1
(en)
*
|
2006-07-24 |
2009-06-17 |
Gilead Sciences, Inc. |
Bisfuranyl protease inhibitors
|
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
|
EA016267B1
(ru)
|
2006-09-29 |
2012-03-30 |
Айденикс Фармасьютикалз, Инк. |
Энантиомерно чистые фосфоиндолы в качестве ингибиторов hiv
|
|
EP2121589A2
(en)
*
|
2006-12-18 |
2009-11-25 |
University of Massachusetts |
Crystal structures of hiv-1 protease inhibitors bound to hiv-1 protease
|
|
EP2134336B1
(en)
*
|
2007-03-16 |
2013-12-11 |
Sequoia Pharmaceuticals |
Benzofuran-derived hiv protease inhibitors
|
|
CN101702908A
(zh)
*
|
2007-03-23 |
2010-05-05 |
麻萨诸塞州大学 |
Hiv-1蛋白酶抑制剂
|
|
KR20100024920A
(ko)
*
|
2007-05-03 |
2010-03-08 |
인터뮨, 인크. |
Ｃ형 간염 바이러스 복제의 신규 마크로사이클릭 저해제
|
|
WO2008151306A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Synthesis of cyclodepsipeptide compounds having antineoplastic and/or antimicrobial activity
|
|
JP2010532350A
(ja)
|
2007-06-29 |
2010-10-07 |
コレア リサーチ インスティテュート オブ ケミカル テクノロジー |
新規のｈｉｖ逆転写酵素阻害剤
|
|
KR20100041798A
(ko)
|
2007-06-29 |
2010-04-22 |
한국화학연구원 |
신규 ｈｉｖ 역전사효소 억제제
|
|
US7964843B2
(en)
|
2008-07-18 |
2011-06-21 |
The George Washington University |
Three-dimensional molecular imaging by infrared laser ablation electrospray ionization mass spectrometry
|
|
US20100285446A1
(en)
*
|
2007-07-20 |
2010-11-11 |
Akos Vertes |
Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
|
|
US8067730B2
(en)
|
2007-07-20 |
2011-11-29 |
The George Washington University |
Laser ablation electrospray ionization (LAESI) for atmospheric pressure, In vivo, and imaging mass spectrometry
|
|
US8901487B2
(en)
*
|
2007-07-20 |
2014-12-02 |
George Washington University |
Subcellular analysis by laser ablation electrospray ionization mass spectrometry
|
|
US8119800B2
(en)
|
2007-12-21 |
2012-02-21 |
Korea Research Institute Of Chemical Technology |
Processes for preparing HIV reverse transcriptase inhibitors
|
|
US8993542B2
(en)
*
|
2008-01-25 |
2015-03-31 |
Chimerix Inc. |
Methods of treating viral infections
|
|
AU2009249443A1
(en)
*
|
2008-04-15 |
2009-11-26 |
Intermune, Inc. |
Novel macrocyclic inhibitors of hepatitis C virus replication
|
|
EP2300013B1
(en)
*
|
2008-05-21 |
2017-09-06 |
Ariad Pharmaceuticals, Inc. |
Phosphorous derivatives as kinase inhibitors
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
MX2010014557A
(es)
*
|
2008-06-26 |
2011-02-15 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil)((r)-1-((s)-2-(metilamino)-3-((r)-te trahidro-2h-piran-3-il)propilcarbamoil)piperidin-3-il)metoxi)etil carbamato de metilo.
|
|
BRPI0915878A2
(pt)
|
2008-07-08 |
2015-11-03 |
Gilead Sciences Inc |
sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
|
|
WO2010045266A1
(en)
*
|
2008-10-15 |
2010-04-22 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
|
NZ593648A
(en)
|
2008-12-23 |
2013-09-27 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
|
EP2376514A2
(en)
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Nucleoside analogs
|
|
AR075584A1
(es)
*
|
2009-02-27 |
2011-04-20 |
Intermune Inc |
COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
|
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
EP2270021A1
(en)
|
2009-06-18 |
2011-01-05 |
Centre National de la Recherche Scientifique |
Phosphonates synthons for the synthesis of phosphonates derivatives showing better bioavailability
|
|
WO2010151476A2
(en)
*
|
2009-06-25 |
2010-12-29 |
Gilead Sciences, Inc. |
Crystalline forms of (3r, 3as, 6ar) - hexahydrofuro [2,3-b] furan-3-yl (1s,2r) - (1-{4-[ (diethoxyphosphoryl) methoxy] pheny1}-3-hydroxy-4- [4-methoxy-n- (2-methylpropyl) benzenesul - fonamido] butan-2-yl) carbamate
|
|
US7924650B2
(en)
*
|
2009-06-30 |
2011-04-12 |
Oracle America, Inc. |
Dynamically controlled voltage regulator for a memory
|
|
BRPI1015363A2
(pt)
|
2009-07-02 |
2015-08-25 |
Newgen Therapeutics Inc |
Compostos de quinazolina contendo fósforo, uso dos mesmos, composição e kit
|
|
US8614200B2
(en)
|
2009-07-21 |
2013-12-24 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
|
DE102009041443A1
(de)
*
|
2009-09-16 |
2011-03-31 |
Archimica Gmbh |
Salze des 6-Chlor-4-(cyclopropylethinyl)-1,4-dihydro-4-(trifluormethyl)-2H-3,1-benzoxazin-2-ons und deren Synthese, Aufreinigung und Anwendung als Vorstufen für Efavirenz
|
|
CN102712644A
(zh)
*
|
2009-09-28 |
2012-10-03 |
豪夫迈·罗氏有限公司 |
丙肝病毒复制的新型大环抑制剂
|
|
WO2011041551A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
|
CA2779473C
(en)
*
|
2009-10-30 |
2016-08-16 |
Chimerix, Inc. |
Methods of treating viral associated diseases
|
|
US9006218B2
(en)
|
2010-02-12 |
2015-04-14 |
Chimerix Inc. |
Nucleoside phosphonate salts
|
|
KR101715981B1
(ko)
|
2010-03-31 |
2017-03-13 |
길리애드 파마셋 엘엘씨 |
뉴클레오사이드 포스포르아미데이트
|
|
EP2552933A1
(en)
|
2010-03-31 |
2013-02-06 |
Gilead Pharmasset LLC |
Purine nucleoside phosphoramidate
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
AU2011248620B2
(en)
|
2010-04-26 |
2015-11-26 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
|
US8841275B2
(en)
|
2010-11-30 |
2014-09-23 |
Gilead Pharmasset Llc |
2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
|
|
CN102127030B
(zh)
*
|
2011-01-21 |
2013-05-22 |
天津大学 |
4-(取代-1,3-二炔基)-4-(三氟甲基)苯并-1,4-二氢噁嗪-2-酮类化合物及其制备方法和应用
|
|
JP5999177B2
(ja)
|
2011-05-04 |
2016-09-28 |
アリアド・ファーマシューティカルズ・インコーポレイテッド |
Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物
|
|
TWI635093B
(zh)
*
|
2011-05-19 |
2018-09-11 |
基利科學股份有限公司 |
用於製備抗ｈｉｖ藥劑的方法與中間物
|
|
US8829426B2
(en)
|
2011-07-14 |
2014-09-09 |
The George Washington University |
Plume collimation for laser ablation electrospray ionization mass spectrometry
|
|
EP2548991B1
(en)
*
|
2011-07-18 |
2014-03-05 |
ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) |
Machine for coating an optical article with an anti-soiling coating composition and method for using the machine
|
|
AU2012345732B2
(en)
|
2011-11-30 |
2016-07-14 |
Emory University |
Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
|
|
CA3085086C
(en)
|
2011-12-06 |
2023-08-08 |
Delta Faucet Company |
Ozone distribution in a faucet
|
|
US20150166591A1
(en)
|
2012-05-05 |
2015-06-18 |
Ariad Pharmaceuticals, Inc. |
Methods and compositions for raf kinase mediated diseases
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
SI2970346T1
(sl)
|
2013-03-15 |
2018-12-31 |
The Regents Of The University Of California |
Aciklični diestri nukleozid fosfonata
|
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
|
KR102466389B1
(ko)
|
2014-03-14 |
2022-11-11 |
올텍 법인회사 |
셀레노유기 화합물의 조성물 및 이의 사용 방법
|
|
JPWO2016039403A1
(ja)
*
|
2014-09-11 |
2017-06-29 |
塩野義製薬株式会社 |
持続性ｈｉｖプロテアーゼ阻害剤
|
|
EP3194411B1
(en)
|
2014-09-15 |
2022-05-04 |
The Regents of the University of California |
Nucleotide analogs
|
|
EP3212196A4
(en)
|
2014-10-29 |
2018-07-11 |
Wisconsin Alumni Research Foundation |
Boronic acid inhibitors of hiv protease
|
|
HRP20211456T1
(hr)
|
2014-12-26 |
2021-12-24 |
Emory University |
Protuvirusni derivati n4-hidroksicitidina
|
|
WO2016187788A1
(en)
|
2015-05-25 |
2016-12-01 |
Merck Sharp & Dohme Corp. |
Fused tricyclic heterocyclic compounds useful for treating hiv infection
|
|
US10377782B2
(en)
|
2015-09-15 |
2019-08-13 |
The Regents Of The University Of California |
Nucleotide analogs
|
|
WO2017048252A1
(en)
|
2015-09-15 |
2017-03-23 |
Alltech, Inc. |
Compositions of selenoorganic compounds and methods of use thereof
|
|
EP3368574A1
(en)
|
2015-10-30 |
2018-09-05 |
NBE-Therapeutics AG |
Anti-ror1 antibodies
|
|
EP3377066B1
(en)
|
2015-11-17 |
2021-04-07 |
Merck Sharp & Dohme Corp. |
Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors
|
|
CA3007437C
(en)
|
2015-12-21 |
2021-09-28 |
Delta Faucet Company |
Fluid delivery system including a disinfectant device
|
|
SG11201806120WA
(en)
|
2016-01-20 |
2018-08-30 |
Scripps Research Inst |
Ror1 antibody compositions and related methods
|
|
CN107709288A
(zh)
*
|
2016-02-03 |
2018-02-16 |
四川海思科制药有限公司 |
一种磷酰胺衍生物及制备方法和用途
|
|
CN106045874B
(zh)
*
|
2016-05-20 |
2017-12-05 |
大连医科大学 |
二苯甲酮‐二酮酸类化合物，组合物及用途
|
|
BR112019011074B1
(pt)
|
2016-12-02 |
2021-01-19 |
Merck Sharp & Dohme Corp. |
Compostos heterocíclicos tricíclicos inibidores de hiv integrase, composição que oscompreende e uso dos mesmos
|
|
JOP20190130A1
(ar)
|
2016-12-02 |
2019-06-02 |
Merck Sharp & Dohme |
مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
|
|
JP7194113B2
(ja)
*
|
2017-03-16 |
2022-12-21 |
エボルブ バイオロジクス インコーポレイテッド |
アルブミンの精製方法
|
|
CN109305990B
(zh)
*
|
2017-07-28 |
2021-02-26 |
四川海思科制药有限公司 |
一种磷酸衍生物及制备方法和用途
|
|
CN109305989B
(zh)
*
|
2017-07-28 |
2021-02-26 |
四川海思科制药有限公司 |
一种磷酰胺衍生物及制备方法和用途
|
|
EP3661937B1
(en)
|
2017-08-01 |
2021-07-28 |
Gilead Sciences, Inc. |
Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections
|
|
CN111133002B
(zh)
|
2017-08-07 |
2024-05-24 |
恩比伊治疗股份公司 |
具有高体内耐受性的基于蒽环类药的抗体药物缀合物
|
|
KR102248165B1
(ko)
|
2017-12-07 |
2021-05-06 |
에모리 유니버시티 |
N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도
|
|
US11542288B2
(en)
*
|
2020-06-01 |
2023-01-03 |
University Of Massachusetts |
Antiviral compounds
|
